Nano-X Imaging (NNOX) Change in Account Payables (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Change in Account Payables of -$632000.0 for Q1 2026, down 69.44% year-on-year from -$2.1 million in Q1 2025, and down 155.44% on a QoQ basis from $1.1 million in Q4 2025.
Nano-X Imaging (NNOX) Change in Account Payables (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Change in Account Payables for 6 consecutive years, with -$632000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Account Payables fell 69.44% year-over-year to -$632000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29000.0 (up 111.79% YoY) and the FY2025 annual result came in at $288000.0, up 121.88% from the prior year.
- Change in Account Payables fell to -$632000.0 in Q1 2026 per NNOX's latest filing, from $1.1 million in the prior quarter.
- Over the last five years, Change in Account Payables for NNOX reached as high as $4.0 million in Q3 2022 and fell as low as -$2.3 million in Q3 2023.
- A 5-year average of -$79058.8 and a median of -$239000.0 in 2024 frame the typical range for Change in Account Payables.
- The largest YoY upside for Change in Account Payables was 2668.75% in 2022 against a maximum downside of 2018.68% in 2022.
- Year by year, Change in Account Payables stood at -$2.0 million in 2022, then surged by 162.21% to $1.2 million in 2023, then plunged by 46.45% to $656000.0 in 2024, then jumped by 73.78% to $1.1 million in 2025, then plunged by 155.44% to -$632000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$632000.0, $1.1 million, and -$530000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | - |
| 10 | Nano-X Imaging | 63,415.95 | -44.16 Mn | -2.59 Mn | -632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -632,000.00 |
| Mar 31, 2026 | -632,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | -530,000.00 |
| Sep 30, 2025 | -530,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | -373,000.00 |
| Mar 31, 2025 | -373,000.00 |
| Dec 31, 2024 | 656,000.00 |
| Dec 31, 2024 | 656,000.00 |
| Sep 30, 2024 | -239,000.00 |
| Sep 30, 2024 | -239,000.00 |
| Jun 30, 2024 | -290,000.00 |
| Jun 30, 2024 | -290,000.00 |
| Mar 31, 2024 | -1.44 Mn |
| Mar 31, 2024 | -1.44 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2023 | 1.23 Mn |